Accessibility Menu
AmeriCann logo

AmeriCann(OTC) ACAN

Market Cap$2.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-100%
5 Year-100%
1 Year+0%
1 Month+900%
$0.00
+0.00%
+0.00Today
AmeriCann last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-03
AmeriCann stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-27
1 month+900%USD 0.002026-07-01
3 month+0%USD 0.002026-05-05
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-07-31
3 year-99.95%USD 0.222023-08-04
5 year-99.99%USD 1.012021-08-04
Since inception-100%USD 5.502014-07-10

AmeriCann Financials at a Glance

Market Cap

$2.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.27M

Net Income (TTM)

-$2.38M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

21.06 (High)

Price

$0.00

Volume

5

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.12

Estimated Earnings Date

Feb 12, 2026

ACAN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AmeriCann

AmeriCann, Inc. is a specialized cannabis enterprise based in Denver, Colorado, providing a comprehensive range of services to authorized cannabis businesses across the United States. The company focuses on the conception, construction, leasing, and management of facilities essential for cannabis cultivation, processing, and manufacturing.

Products and Services
  • Facility design and construction for cannabis operations
  • Leasing services for cannabis cultivation and processing facilities
  • Management services for cannabis production and distribution
Growth Outlook
  • Massachusetts Cannabis Center development spans 52 acres, enhancing operational capacity
  • Increasing demand for both medical and recreational cannabis products
  • Strategic positioning in a rapidly growing cannabis market
Financial Highlights
  • Recent quarterly revenue of $475,629, showing potential for growth
  • Gross profit margin of 99.8% in the latest quarter indicates strong operational efficiency
  • Trailing twelve months (TTM) revenue of $1,174,000 reflects a solid revenue base
AmeriCann, Inc. operates in a dynamic and expanding sector, with a focus on providing essential services to cannabis businesses. The Massachusetts Cannabis Center represents a significant investment in infrastructure, positioning the company to capitalize on the growing demand for cannabis products. Recent financial performance indicates a strong gross profit margin, suggesting effective cost management and operational efficiency. The company's revenue trajectory, alongside its strategic initiatives, highlights its potential for future growth in the evolving cannabis landscape.
AI Generated • Jul 24, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

3

CEO

Tim Keogh

Website

www.americann.co

Headquarters

Denver, CO 80202, US

ACAN Financials

Key Financial Metrics (TTM)

Gross Margin

99.76%

Operating Margin

-58.51%

Net Income Margin

-98.35%

Return on Equity

-24.68%

Return on Capital

-5.43%

Return on Assets

-8.92%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

24.39M

Volume

5

Avg. Volume

686.333

Financials (TTM)

Gross Profit

$1.14M

Operating Income

-$1.15M

EBITDA

-$1.33M

Operating Cash Flow

-$1.42M

Capital Expenditure

-$3.83K

Free Cash Flow

-$1.43M

Cash & ST Invst.

$131.16K

Total Debt

$6.79M

AmeriCann Performance Analysis

AmeriCann annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-09-30USD 2,028,551N/A
20222022-09-30USD 2,927,81944.3%
20232023-09-30USD 2,552,200-12.8%
20242024-09-30USD 1,274,810-50.1%
AmeriCann sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-03-31-4.6%
Q32024-06-30-61.9%
Q42024-09-30N/A
Q12024-12-31175.3%
AmeriCann annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-09-30USD -0.04N/A
20222022-09-30USD -0.01-80.4%
20232023-09-30USD -0.00-45.1%
20242024-09-30USD -0.051217.9%
AmeriCann sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-03-312.9%
Q32024-06-30-176.5%
Q42024-09-30N/A
Q12024-12-31-183.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$475.63K

+0.0%

Gross Profit

$474.85K

+0.0%

Gross Margin

99.84%

N/A

Market Cap

$2.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$800.00

N/A

Employees

3

N/A

Net Income

-$1.30M

-655.2%

EBITDA

-$1.06M

-1161.2%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Total Cash

$131.16K

-83.8%

Total Debt

$6.79M

-27.0%

Accounts Receivable

$229.48K

-48.2%

Inventory

$0.00

N/A

Long Term Debt

$1.70M

-59.5%

Short Term Debt

$5.09M

-0.2%

Return on Assets

-8.92%

N/A

Return on Invested Capital

-8.63%

N/A

Free Cash Flow

-$596.33K

-76.8%

Operating Cash Flow

-$593.47K

-76.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HHBTHH Biotechnology Holdings Company
$0.00+0.00%
XXFPLFFP Partners, L.P.
$0.00-0.00%
CRXPFVert Infrastructure Ltd.
$0.00+0.00%
SFRTAppreciate Holdings, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About ACAN

What is the current price of AmeriCann?

AmeriCann is trading at $0.00 per share.

What is the 52-week range for AmeriCann?

Over the past 52 weeks, AmeriCann has traded between $0.00 and $0.12.

How much debt does AmeriCann have?

As of the most recent reporting period, AmeriCann reported total debt of $6.79M.

How much cash does AmeriCann have on hand?

AmeriCann reported $141.12K in cash and cash equivalents in its most recent financial results.

What is AmeriCann’s dividend yield?

AmeriCann does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services